These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

896 related items for PubMed ID: 29335335

  • 1. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.
    Ntaios G, Papavasileiou V, Sagris D, Makaritsis K, Vemmos K, Steiner T, Michel P.
    Stroke; 2018 Feb; 49(2):412-418. PubMed ID: 29335335
    [Abstract] [Full Text] [Related]

  • 2. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.
    Ntaios G, Papavasileiou V, Makaritsis K, Michel P.
    Int J Cardiol; 2013 Oct 30; 169(2):101-5. PubMed ID: 24041984
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W, FORI (Foramen Ovale Registro Italiano) Investigators.
    Cerebrovasc Dis; 2011 Oct 30; 31(2):109-16. PubMed ID: 21088390
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
    Sitwala P, Khalid MF, Khattak F, Bagai J, Bhogal S, Ladia V, Mukherjee D, Daggubati R, Paul TK.
    Cardiovasc Revasc Med; 2019 Aug 30; 20(8):687-694. PubMed ID: 30282597
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.
    Pickett CA, Villines TC, Ferguson MA, Hulten EA.
    Tex Heart Inst J; 2014 Aug 30; 41(4):357-67. PubMed ID: 25120387
    [Abstract] [Full Text] [Related]

  • 9. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
    Schulze V, Lin Y, Karathanos A, Brockmeyer M, Zeus T, Polzin A, Perings S, Kelm M, Wolff G.
    Clin Res Cardiol; 2018 Sep 30; 107(9):745-755. PubMed ID: 29500568
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.
    Zhang XL, Kang LN, Wang L, Xu B.
    BMC Cardiovasc Disord; 2018 Mar 02; 18(1):45. PubMed ID: 29499641
    [Abstract] [Full Text] [Related]

  • 11. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
    Mazzucco S, Li L, Rothwell PM.
    JAMA Neurol; 2020 Oct 01; 77(10):1279-1287. PubMed ID: 32628255
    [Abstract] [Full Text] [Related]

  • 12. Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.
    Alushi B, Lauten A, Cassese S, Colleran R, Schüpke S, Rai H, Schunkert H, Meier B, Landmesser U, Kastrati A.
    Clin Res Cardiol; 2018 Sep 01; 107(9):788-798. PubMed ID: 29644412
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis.
    Sagris D, Georgiopoulos G, Perlepe K, Pateras K, Korompoki E, Makaritsis K, Vemmos K, Milionis H, Ntaios G.
    Stroke; 2019 Nov 01; 50(11):3135-3140. PubMed ID: 31547797
    [Abstract] [Full Text] [Related]

  • 15. Patent foramen ovale closure versus medical therapy after cryptogenic stroke: An updated meta-analysis of all randomized clinical trials.
    Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G.
    Cardiol J; 2019 Nov 01; 26(1):47-55. PubMed ID: 29512097
    [Abstract] [Full Text] [Related]

  • 16. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
    Fortuni F, Crimi G, Leonardi S, Angelini F, Raisaro A, Lanzarini LF, Oltrona Visconti L, Ferrario M, De Ferrari GM.
    J Cardiovasc Med (Hagerstown); 2018 Jul 01; 19(7):373-381. PubMed ID: 29708911
    [Abstract] [Full Text] [Related]

  • 17. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses.
    Udell JA, Opotowsky AR, Khairy P, Silversides CK, Gladstone DJ, O'Gara PT, Landzberg MJ.
    Can J Cardiol; 2014 Oct 01; 30(10):1216-24. PubMed ID: 25154803
    [Abstract] [Full Text] [Related]

  • 18. Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale.
    Spencer FA, Lopes LC, Kennedy SA, Guyatt G.
    BMJ Open; 2014 Mar 07; 4(3):e004282. PubMed ID: 24607561
    [Abstract] [Full Text] [Related]

  • 19. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
    Lattanzi S, Brigo F, Cagnetti C, Di Napoli M, Silvestrini M.
    Cerebrovasc Dis; 2018 Mar 07; 45(5-6):193-203. PubMed ID: 29649819
    [Abstract] [Full Text] [Related]

  • 20. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis.
    Xu HB, Zhang H, Qin Y, Xue F, Xiong G, Yang L, Bai H, Wu J.
    J Neurol Sci; 2018 Jul 15; 390():139-149. PubMed ID: 29801875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.